Polycystic ovary syndrome (PCOS) occurs in 6 to 10% of women during the reproductive age. Insulin resistance and compensatory hyperinsulinemia are currently two of the main factors involved in the etiopathogenesis of PCOS. The objective of the present review was to discuss the controversies related to the treatment of infertile women with PCOS and during their pregnancy, focusing on the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) current consensus.
Santana LF, Ferriani RA, Sá MFS, Reis RM. Treatment of infertility in women with polycystic ovary syndrome. Rev Bras Ginecol Obstet 2008;30(4):201-9.
Electronic Document Format (ABNT)
Santana, Laura Ferreira; Ferriani, Rui Alberto; Sá, Marcos Felipe Silva de; Reis, Rosana Maria dos. Treatment of infertility in women with polycystic ovary syndrome. Rev Bras Ginecol Obstet, v. 30, n. 4, p. 201-209, Jul. 2008.
Electronic Document Format (APA)
Santana, L. F., Ferriani, R. A., Sá, M. F. S. , & Reis, R. M. (2008). Treatment of infertility in women with polycystic ovary syndrome. Rev Bras Ginecol Obstet, 30(4), 201-209.
Electronic Document Format (ISO)
Santana, Laura Ferreira and Ferriani, Rui Alberto and Sá, Marcos Felipe Silva de and Reis, Rosana Maria dos. Treatment of infertility in women with polycystic ovary syndrome. Rev Bras Ginecol Obstet [online]. 2008, vol. 30, n. 4, [cited 2024-06-28], pp.201-209. Available from: <https://journalrbgo.org/article/treatment-of-infertility-in-women-with-polycystic-ovary-syndrome/>.
Comments